Newer therapies for vasculitis.

  title={Newer therapies for vasculitis.},
  author={Thomas F. Hiemstra and David R. W. Jayne},
  journal={Best practice & research. Clinical rheumatology},
  volume={23 3},
There is a clear unmet need in the therapy of vasculitis reflecting the toxicity and partial efficacy of conventional agents. Vasculitis is a complex area for the evaluation of newer therapies due to the heterogeneity between and within syndromes with multisystem manifestations. Much of the evidence supporting newer therapies comes from small, non-randomised trials and is insufficient to permit firm recommendations. Newer immunosuppressive drugs, including mycophenolic acid and leflunomide, are… CONTINUE READING

Similar Papers

Loading similar papers…